140. Breast Cancer Res. 2018 Jul 9;20(1):68. doi: 10.1186/s13058-018-1000-4.Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.Shapira M(1)(2), Kakiashvili E(3), Rosenberg T(2), Hershko DD(4)(5)(6).Author information: (1)Department of Surgery A, Rambam Medical Center, 31096, Haifa, Israel.(2)Technion - Israel Institute of Technology, 31096, Haifa, Israel.(3)Department of Surgery B, Rambam Medical Center, 31096, Haifa, Israel.(4)Department of Surgery A, Rambam Medical Center, 31096, Haifa, Israel.d_hershko@rambam.health.gov.il.(5)Technion - Israel Institute of Technology, 31096, Haifa, Israel.d_hershko@rambam.health.gov.il.(6)Breast Health Institute, Rambam Medical Center, 31096, Haifa, Israel.d_hershko@rambam.health.gov.il.Erratum for    Breast Cancer Res. 2006;8(4):R46.After the publication of this work [1], an error was noticed in Fig. 2b, Fig. 3a and Fig. 5b. The Skp1 loading control was accidentally duplicated. We apologizefor this error, which did not affect any of the interpretations or conclusions ofthe article.DOI: 10.1186/s13058-018-1000-4 PMCID: PMC6036680PMID: 29986739 